CARsgen Therapeutics Opens CAR T-cell Manufacturing Facility in Shanghai
May 03, 2017
SHANGHAI,?May 3, 2017?/PRNewswire/ -- CARsgen Therapeutics (CARsgen), a global leader in developing chimeric antigen receptor T-cell (CAR-T cell) therapies for solid tumors, has announced the opening of its new manufacturing facility in?Shanghai.